[250 Pages Report] Global sales of transradial closure devices are set to enjoy a market valuation of US$ 225.4 Million in 2022, and further progress at a high CAGR of 6.8% to reach US$ 381.4 Million through 2030.
The transradial closure devices market currently accounts for 19.3% share in the global vascular closure devices market. Rising number of cardiac cases is primarily expected to increase sales of transradial closure equipment.
Attribute | Details |
---|---|
Transradial Closure Devices Market Size (2022) | US$ 225.4 million |
Revenue Forecast (2030) | US$ 381.4 million |
Global Market Growth Rate (2022 to 2030) | 6.8% CAGR |
North America Market Share | 38.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 6.62% |
H1, 2022 Projected | 6.80% |
H1, 2022 Outlook | 6.70% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (+) 08 ↑ |
The variation between the BPS values observed within this market in H1, 2022 - outlook over H1, 2022 projected reflects a decline of 10 BPS units. However, a positive BPS growth in H1-2022 over H1-2021 by 08 Basis Point Share (BPS) is demonstrated by the market.
The market observes a reduction in BPS due to the limitations associated with transradial closure devices in access site crossover, thus diminishing positive procedure outcomes. Moreover, with advanced product launches, there is an increasing need for trained professionals for device usage, which presents an additional burden upon medical facilities with staffing based costs.
However, with the advent of bioresorbable technologies within the transradial closure devices market space, the market is set to present a positive growth outlook during the forecasted years. With improved safety of newly launched vascular closure devices, the market for transradial closure devices will also witness a boost.
The market is subject to changes as per device regulations, licensing, disease epidemiology, and product adoption rates, in accordance to the macro and industry dynamics.
For radial artery closure, transradial closure devices have developed as a viable alternative for conventional mechanical compression. Improved patient satisfaction with minimum irritation and early patient discharge are all advantages of these devices. The market is expected to see increased product demand as a result of its favourable applications.
The transradial closure devices market expanded at a CAGR of 4.8% from 2015 to 2021, and accumulated revenue worth US$ 212.5 Mn in 2021. Over the coming years, rising risk of heart stroke combined with a burgeoning population suffering from multiple vascular illnesses will drive market expansion.
Hospitals, independent catheterization centers, and healthcare clinics will continue to increase their demand, according to Future Market Insights (FMI). As a result of this, the global transradial closure devices market is expected to expand at a 6.8% CAGR from 2022 to 2030, and reach an estimated net worth of US$ 381.4 Mn through 2030.
Transradial closure systems use the radial artery rather than the femoral artery, which has the advantage of producing a reduced artery calibre while reducing the risk of severe access site haemorrhage. As a result, healthcare professionals and patients alike favour transradial closure units.
“Rising Incidence of Cardiovascular Diseases Surging Sales of Transradial Closure Devices”
Demand for efficient therapy for cardiovascular disorders is driving sales of transradial closure devices. According to the World Health Organization (WHO), cardiovascular illnesses claim the lives of roughly 17.9 million people each year, accounting for 31% of all fatalities globally.
The need for transradial closure devices is steadily increasing as healthcare segments become more advanced by being equipped with cutting-edge surgical and diagnostic instruments.
Transradial closure systems, which represent a breakthrough in modern interventional cardiology, are gaining acceptance around the world due to their ability to provide a more convenient location for safe calibration with less risk and discomfort.
“Clinical Research Encouraging Adoption of Transradial Closure Technologies in Healthcare Facilities”
Transradial access has been shown in clinical investigations to help reduce vascular and bleeding problems. In addition, the use of transradial closure devices reduces the likelihood of site injury.
Transradial closure equipment is getting popular in the healthcare business because they give superior comfort and reduce the risk of harm as compared to traditional methods.
Hospitals, diagnostic centers, and other healthcare facilities have started to adopt current technology and instruments as a result of digital improvements, which is driving the demand curve for transradial closure devices higher.
Transradial closure devices are frequently used during coronary angiography, angioplasty, and other medical operations because they are more efficient in terms of safety, comfort, and accuracy. Transradial access is more effective in clinical investigations all around the world.
With the tendency unlikely to abate over the coming years, FMI anticipates a significant increase in demand for transradial closure devices.
“Lack of Skilled Healthcare Workers May Impede Transradial Closure Device Usage”
Transradial closure devices require unique knowledge, care, and safeguards when used. Despite the superficial position and simplicity of compression, radial access difficulties can occur, resulting in bleeding and damage at the access site.
As a result, it is critical to have sufficient understanding to handle the complete operation, which may function as a barrier to its general adoption.
“COVID-19 Pandemic Affected Production of Transradial Closure Devices”
Furthermore, the COVID-19 pandemic has had a significant impact on the transradial closure devices market because of production and distribution challenges during the extended lockdown period. Transradial closure devices are more expensive than traditional closure devices.
Besides, large costs are paid for their upkeep, which may result in a decrease in demand. Furthermore, despite clinical studies stressing the advantages of the transradial technique, many operators prefer to employ the femoral approach due to familiarity with the procedure.
“North America Leads Transradial Closure Devices Market Due to Increasing Cases of Cardiac Illnesses”
North America dominates the global transradial closure devices market and is projected to do so over the forecast period. The North America transradial closure devices market is being driven by an increase in the incidence of various cardiovascular illnesses such as coronary heart disease, cardiac arrest, hypertension, and others caused by food habits, lifestyle, and other factors.
As more people become conscious of cardiac health, the market for transradial closure devices in North America is seeing an increase in demand due to increased diagnostics utilization. At present, North America is expected to account for 38.3% of the global market share.
Europe is the second-largest market for transradial closure devices, and it is expected to remain so over the forecast period. The Europe transradial closure devices market is being boosted by advancements in major end-use industries such as independent catheterization centers, hospitals, specialty clinics, and others. Currently, Europe is likely to hold 33.5% of the global market share.
Cardiovascular disease accounts for more than half of all fatalities in Europe, according to the World Health Organization, and 80 percent of premature heart disease and stroke are preventable. The demand for transradial closure devices is expanding tremendously as more people obtain knowledge about improving cardiovascular health.
South Asia has emerged as a viable market for transradial closure devices, with steady growth projected in the coming years. The healthcare industry in South Asia is steadily increasing, according to the World Health Organization.
As a result, the market for transradial closure devices in South Asia is expected to expand. The increasing use of transradial closure devices in surgical and diagnostic procedures is expected to propel the South Asia transradial closure devices market forward over the forecast period.
In 2022, South Asia, East Asia, and Oceania together are predicted to account for 20.6% of the global market share. While Latin America and MEA are likely to account for 4.6% and 3% of the global market share respectively in 2022.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
How is Demand for Transradial Closure Devices Expected to Shape Up in U.S.?
“Growing Fear of Cardiovascular Disease & Advanced Healthcare Infrastructure Driving Demand for Transradial Closure Devices”
The United States is likely to dominate the North America transradial closure devices market. The high prevalence of the heart disease necessitates the use of transradial closure devices, which drives the market's growth in the country.
According to a research published by the Centers for Disease Control and Prevention, "In the United States, heart disease is the top cause of death for men, women, and people of most racial and ethnic groups. In the United States, one person dies from cardiovascular disease every 36 seconds. Heart disease claims the lives of around 659,000 people in the United States each year, accounting for one out of every four deaths".
Furthermore, the market in the country is aided by modern infrastructure and rising healthcare spending among the populace.
What is the Market Stabce for Transradial Closure Device Producers in India?
“Presence of Improved Healthcare Systems Boosts Demand for Transradial Closure Devices”
India is set to be a growing market for the healthcare industry. In terms of revenue and employment, healthcare has become one of India's most important industries.
The Indian healthcare system is expanding rapidly as a result of improved coverage, services, and increased spending by both public and private entities. In addition, the country's well-developed manufacturing activities and healthcare system are expanding the transradial closure devices market forward.
“Bands or Straps to Be Leading Transradial Closure Devices Due to their Advanced Features”
Transradial closure devices with a band or strap have a success rate in helping radial artery haemostasis following transradial surgery. This type of transradial closure device has several advantages, including the capacity to selectively compress the radial artery to enable blood flow while maintaining patency, the availability of preferred band lengths for exact fit and best patient comfort, and so on.
In terms of product type, band- or strap-based transradial closure devices currently lead the transradial closure devices market and are projected to continue to do so in the coming years due to increased demand for their unique features.
“Efficient & Effective Quality Make Disposable Devices Prominent Selling Product”
Disposable devices are the most preferred since they are cost-effective and require no maintenance. Disposable devices are in high demand among a wide range of end users, from hospitals to ambulatory surgical clinics.
Disposable devices are popular because they are efficient for one-time diagnosis and surgical intervention. Disposable devices will be the most prevalent throughout the predicted period, according to FMI.
“Rising Heart Illnesses & Growing Awareness of Diagnostics to Fuel Demand for Transradial Closure Devices”
Increasing occurrences of cardiovascular illnesses and rising patient awareness are driving the use of transradial closure devices in the diagnostic segment. The diagnostic segment is anticipated to maintain its advantage in the coming years, according to FMI.
Because transradial closure devices are less expensive than transfemoral closure devices, diagnosis centers prefer them for mild to severe cases. Furthermore, the lower hazards associated with the diagnostic method have made it the leading choice in this segment.
“High Consumption of Transradial Closure Devices by Independent Catheterization Centers Due to their Specialized Features”
Catheterization facilities are specialized hospital rooms where minimally invasive tests and treatments are performed to detect and treat cardiovascular problems.
As the prevalence of cardiovascular disorders rises, the number of independent catheterization centers is increasing to serve the growing patient pool. This segment currently dominates the worldwide transradial closure devices market and is expected to do so over the forecast period.
Patients who require invasive interventional procedures as an alternative to surgery should seek out independent catheterization centers. Furthermore, a large section of the population with cardiovascular illness prefers independent cardiac catheterization laboratories because they are solely focused on the diagnosis and treatment of this disease.
Because the market is so competitive, major competitors are focusing their efforts on introducing cutting-edge technology and equipment.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2030 |
Historical Data Available for | 2015 to 2021 |
Market Analysis | US$ million for Value, Units for Volume |
Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Pacific; Middle East & Africa (MEA) |
Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, India, Indonesia, Malaysia, Singapore, Australia, New Zealand, Turkey, South Africa, and GCC Countries |
Key Market Segments Covered | Product, Usage, Application, End User, Region |
Key Companies Profiled | Merit Medical, Inc.; Abbott Laboratories; Fisher & Paykel Healthcare Corporation Ltd.; Vascular Solution Inc.; Advanced Vascular Dynamics; Comed B.V.; Beijing Demax Medical Technology Co., Ltd. |
Pricing | Available upon Request |
Transradial Closure Devices Market by Product:
Transradial Closure Devices Market by Usage:
Transradial Closure Devices Market by Application:
Transradial Closure Devices Market by End User:
Transradial Closure Devices Market by Region:
The global transradial closure devices market is projected to increase from a valuation of US$ 225.4 Mn in 2022 to US$ 381.4 Mn through 2030.
According to Future Market Insights (FMI), the transradial closure devices market is predicted to expand at 6.8% CAGR from 2022 to 2030.
Some of the top companies manufacturing transradial closure devices are Merit Medical, Inc., Comed B.V, Advanced Vascular Dynamics, and Abbott Laboratories.
Band- or strap-based transradial closure devices are witnessing high demand.
Disposable transradial closure devices are most preferred across the world.
Since competition is getting tougher, key market players are focusing on launching ultra-modern, compact transradial closure devices to target diverse end users.
Transradial closure devices are finding increasing applications in diagnostics.
The North America transradial closure devices market currently accounts for 38.3% of the global market share.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Transradial Closure Devices Adoption Rate/Usage Analysis- Key Statistics
4.2. Key Promotional Strategies, By Key Manufacturers
4.3. Key Regulations, By Region
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Improvement in Healthcare infrastructure
5.1.3. Rise in Healthcare Spending
5.1.4. Increase in global geriatric population
5.2. Forecast Factors - Relevance & Impact
5.2.1. Regulatory approvals
5.2.2. New Product launches
5.2.3. Cost of Products
5.2.4. Incidence of cardiovascular disease
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Country
6.5. 2022 Market Scenario
6.6. Quarter by Quarter Forecast
7. Global Transradial Closure Devices Market Volume (Units) Analysis 2015-2021 and Forecast, 2022-2030
7.1. Historical Market volume (Units) Analysis, 2015-2021
7.2. Current and Future Market Volume (Units) Projections, 2022-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.3. Absolute $ Opportunity Analysis
8. Global Transradial Closure Devices Market Pricing Analysis
8.1. Average Pricing Analysis Benchmark
8.2. Pricing Break-up
9. Global Transradial Closure Devices Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030
9.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030, by Product type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Product type, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product type, 2022-2030
10.3.1. Band/ Strap Based
10.3.2. Knob Based
10.3.3. Plate Based
10.4. Market Attractiveness Analysis by Product type
11. Global Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030, by Usage
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) and By Usage , 2015-2021
11.3. Current and Future Market Size (US$ Mn) and Forecast By Usage , 2022-2030
11.3.1. Disposable device
11.3.2. Reusable device
11.4. Market Attractiveness Analysis by Usage
12. Global Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030, by Application
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and By Application , 2015-2021
12.3. Current and Future Market Size (US$ Mn) and Forecast By Application , 2022-2030
12.3.1. Surgical Intervention
12.3.2. Diagnostics
12.4. Market Attractiveness Analysis by Application
13. Global Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030, by End user
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Distribution channel, 2015-2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution channel, 2022-2030
13.3.1. Hospitals
13.3.2. Independent Catheterization Centers
13.3.3. Ambulatory Surgical Centers
13.3.4. Specialized Clinics
13.4. Market Attractiveness Analysis By End user
14. Global Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030, by Region
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2021
14.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2030
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. East Asia
14.3.5. South Asia
14.3.6. Oceania
14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis By Region
15. North America Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2030
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Product Type
15.3.3. By Usage
15.3.4. By Application
15.3.5. By Distribution channel
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Latin America Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2030
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By Product Type
16.3.3. By Usage
16.3.4. By application
16.3.5. By End user
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Europe Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy2022-2030
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. U.K.
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Rest of Europe
17.3.2. By Product Type
17.3.3. By Usage
17.3.4. By Application
17.3.5. By End user
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. South Asia Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy2022-2030
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Thailand
18.3.1.3. Indonesia
18.3.1.4. Malaysia
18.3.1.5. Rest of South Asia
18.3.2. By Product Type
18.3.3. By Usage
18.3.4. By Application
18.3.5. By End user
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. East Asia Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2030
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Product Type
19.3.3. By Usage
19.3.4. By Application
19.3.5. By End user
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Oceania Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2030
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Product Type
20.3.3. By Usage
20.3.4. By Application
20.3.5. By End user
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Middle East and Africa Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030
21.1. Introduction
21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
21.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2030
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Turkey
21.3.1.3. South Africa
21.3.1.4. Rest of Middle East and Africa
21.3.2. By Product Type
21.3.3. By Usage
21.3.4. By Application
21.3.5. By End user
21.4. Market Attractiveness Analysis
21.5. Key Market Participants - Intensity Mapping
21.6. Drivers and Restraints - Impact Analysis
22. Key and Emerging Countries Transradial Closure Devices Market Analysis 2015-2021 and Forecast 2022-2030
22.1. Introduction
22.1.1. Market Value Proportion Analysis, By Key Countries
22.1.2. Global Vs. Country Growth Comparison
22.2. U.S. Transradial Closure Devices Market Analysis
22.2.1. By Product Type
22.2.2. By Usage
22.2.3. By Application
22.2.4. By End user
22.3. Canada Transradial Closure Devices Market Analysis
22.3.1. By Product Type
22.3.2. By Usage
22.3.3. By Application
22.3.4. By End user
22.4. Mexico Transradial Closure Devices Market Analysis
22.4.1. By Product Type
22.4.2. By Usage
22.4.3. By Application
22.4.4. By End user
22.5. Brazil Transradial Closure Devices Market Analysis
22.5.1. By Product Type
22.5.2. By Usage
22.5.3. By Application
22.5.4. By End user
22.6. U.K. Transradial Closure Devices Market Analysis
22.6.1. By Product Type
22.6.2. By Usage
22.6.3. By Application
22.6.4. By End user
22.7. Germany Transradial Closure Devices Market Analysis
22.7.1. By Product Type
22.7.2. By Usage
22.7.3. By Application
22.7.4. By End user
22.8. France Transradial Closure Devices Market Analysis
22.8.1. By Product Type
22.8.2. By Usage
22.8.3. By Application
22.8.4. By End user
22.9. Italy Transradial Closure Devices Market Analysis
22.9.1. By Product Type
22.9.2. By Usage
22.9.3. By Application
22.9.4. By End user
22.10. Spain Transradial Closure Devices Market Analysis
22.10.1. By Product Type
22.10.2. By Usage
22.10.3. By Application
22.10.4. By End user
22.11. BENELUX Transradial Closure Devices Market Analysis
22.11.1. By Product Type
22.11.2. By Usage
22.11.3. By Application
22.11.4. By End user
22.12. Russia Transradial Closure Devices Market Analysis
22.12.1. By Product Type
22.12.2. By Usage
22.12.3. By Application
22.12.4. By End user
22.13. China Transradial Closure Devices Market Analysis
22.13.1. By Product Type
22.13.2. By Usage
22.13.3. By Application
22.13.4. By End user
22.14. Japan Transradial Closure Devices Market Analysis
22.14.1. By Product Type
22.14.2. By Usage
22.14.3. By Application
22.14.4. By End user
22.15. South Korea Transradial Closure Devices Market Analysis
22.15.1. By Product Type
22.15.2. By Usage
22.15.3. By Application
22.15.4. By End user
22.16. India Transradial Closure Devices Market Analysis
22.16.1. By Product Type
22.16.2. By Usage
22.16.3. By Application
22.16.4. By End user
22.17. ASEAN Transradial Closure Devices Market Analysis
22.17.1. By Product Type
22.17.2. By Usage
22.17.3. By Application
22.17.4. By End user
22.18. Australia Transradial Closure Devices Market Analysis
22.18.1. By Product Type
22.18.2. By Usage
22.18.3. By Application
22.18.4. By End user
22.19. New Zealand Transradial Closure Devices Market Analysis
22.19.1. By Product Type
22.19.2. By Usage
22.19.3. By Application
22.19.4. By End user
22.20. GCC Countries Transradial Closure Devices Market Analysis
22.20.1. By Product Type
22.20.2. By Usage
22.20.3. By Application
22.20.4. By End user
22.21. Turkey Transradial Closure Devices Market Analysis
22.21.1. By Product Type
22.21.2. By Usage
22.21.3. By Application
22.21.4. By End user
22.22. South Africa Transradial Closure Devices Market Analysis
22.22.1. By Product Type
22.22.2. By Usage
22.22.3. By Application
22.22.4. By End user
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Concentration
23.3. Market Share Analysis of Top Players
23.3.1. Regional footprint of Players
23.3.2. Product type foot print by Players
23.3.3. Channel Foot Print by Players
24. Competition Analysis
24.1. Competition Dashboard
24.2. Competition Deep Dive
24.2.1. Terumo Corporation
24.2.1.1. Overview
24.2.1.2. Product type Portfolio
24.2.1.3. Profitability by Market Segments (Product type/Channel/Region)
24.2.1.4. Sales Footprint
24.2.1.5. Analyst Commentary
24.2.1.6. Strategy Overview
24.2.1.6.1. Marketing Strategy
24.2.1.6.2. Product type Strategy
24.2.1.6.3. Channel Strategy
24.2.2. Merit Medical, Inc.
24.2.2.1. Overview
24.2.2.2. Product type Portfolio
24.2.2.3. Profitability by Market Segments (Product type/Channel/Region)
24.2.2.4. Sales Footprint
24.2.2.5. Analyst Commentary
24.2.2.6. Strategy Overview
24.2.2.6.1. Marketing Strategy
24.2.2.6.2. Product type Strategy
24.2.2.6.3. Channel Strategy
24.2.3. Abbott Laboratories
24.2.3.1. Overview
24.2.3.2. Product type Portfolio
24.2.3.3. Profitability by Market Segments (Product type/Channel/Region)
24.2.3.4. Sales Footprint
24.2.3.5. Analyst Commentary
24.2.3.6. Strategy Overview
24.2.3.6.1. Marketing Strategy
24.2.3.6.2. Product type Strategy
24.2.3.6.3. Channel Strategy
24.2.4. Fisher & Paykel Healthcare Corporation Ltd.
24.2.4.1. Overview
24.2.4.2. Product type Portfolio
24.2.4.3. Profitability by Market Segments (Product type/Channel/Region)
24.2.4.4. Sales Footprint
24.2.4.5. Analyst Commentary
24.2.4.6. Strategy Overview
24.2.4.6.1. Marketing Strategy
24.2.4.6.2. Product type Strategy
24.2.4.6.3. Channel Strategy
24.2.5. . Vascular Solution Inc.
24.2.5.1. Overview
24.2.5.2. Product type Portfolio
24.2.5.3. Profitability by Market Segments (Product type/Channel/Region)
24.2.5.4. Sales Footprint
24.2.5.5. Analyst Commentary
24.2.5.6. Strategy Overview
24.2.5.6.1. Marketing Strategy
24.2.5.6.2. Product type Strategy
24.2.5.6.3. Channel Strategy
24.2.6. Advanced Vascular Dynamics
24.2.6.1. Overview
24.2.6.2. Product type Portfolio
24.2.6.3. Profitability by Market Segments (Product type/Channel/Region)
24.2.6.4. Sales Footprint
24.2.6.5. Analyst Commentary
24.2.6.6. Strategy Overview
24.2.6.6.1. Marketing Strategy
24.2.6.6.2. Product type Strategy
24.2.6.6.3. Channel Strategy
24.2.7. Comed B.V.
24.2.7.1. Overview
24.2.7.2. Product type Portfolio
24.2.7.3. Profitability by Market Segments (Product type/Channel/Region)
24.2.7.4. Sales Footprint
24.2.7.5. Analyst Commentary
24.2.7.6. Strategy Overview
24.2.7.6.1. Marketing Strategy
24.2.7.6.2. Product type Strategy
24.2.7.6.3. Channel Strategy
24.2.8. Beijing Demax Medical Technology co., Ltd.
24.2.8.1. Overview
24.2.8.2. Product type Portfolio
24.2.8.3. Profitability by Market Segments (Product type/Channel/Region)
24.2.8.4. Sales Footprint
24.2.8.5. Analyst Commentary
24.2.8.6. Strategy Overview
24.2.8.6.1. Marketing Strategy
24.2.8.6.2. Product type Strategy
24.2.8.6.3. Channel Strategy
25. Assumptions and Acronyms Used
26. Research Methodology
Explore Healthcare Insights
View Reports